Nucleosome ctDNA
At Goffin, we proudly offer exclusive access to nucleosomal ctDNA (n-ctDNA), a premier reference material known for its exceptionally low mutation background noise. This product enables highly sensitive Limits of Blank (LOB), Detection (LOD), and Quantification (LOQ) in Next Generation Sequencing (NGS) assays, including Minimal Residual Disease (MRD) testing. Derived from SensID’s proprietary lymphoblastoid cell line (BDXXP4), our n-ctDNA features an impressively low error rate and high library conversion efficiency. Its patient-like fragmentation pattern makes it ideal for liquid biopsy research, diagnostics, and clinical trials. Additionally, Goffin can accommodate custom production from other cell lines upon request.
Quote-based, no public pricing. Add to your quote and our specialists put together a proposal with the right documentation, typically within 24 hours.
This kit in detail
At Goffin, we proudly offer exclusive access to nucleosomal ctDNA (n-ctDNA), a premier reference material known for its exceptionally low mutation background noise. This product enables highly sensitive Limits of Blank (LOB), Detection (LOD), and Quantification (LOQ) in Next Generation Sequencing (NGS) assays, including Minimal Residual Disease (MRD) testing.
Derived from SensID’s proprietary lymphoblastoid cell line (BDXXP4), our n-ctDNA features an impressively low error rate and high library conversion efficiency. Its patient-like fragmentation pattern makes it ideal for liquid biopsy research, diagnostics, and clinical trials. Additionally, Goffin can accommodate custom production from other cell lines upon request.
- Optimized for Digital PCR and NGS
- Supports Protocol Validation
- Determines Detection Limits
- Useful for various research and clinical settings
At Goffin, we are proud to be the exclusive supplier of nucleosomal ctDNA (n-ctDNA), a top-tier reference material recognized for its industry-leading low mutation background noise. This product ensures superior sensitivity and precision, making it ideal for achieving the lowest Limits of Blank (LOB), Detection (LOD), and Quantification (LOQ) in Next Generation Sequencing (NGS) assays, including highly specialized Minimal Residual Disease (MRD) tests.
Our n-ctDNA is produced from SensID’s proprietary lymphoblastoid cell line (BDXXP4), offering intensively characterized cfDNA with an exceptionally low error rate and excellent library conversion efficiency. Thanks to its patient-like fragmentation pattern, this reference material is perfectly suited for liquid biopsy research, diagnostic applications, and clinical trials in your laboratory or R&D department.
Additionally, Goffin can facilitate custom production from other cell lines upon request, ensuring flexibility and adaptability to meet specific research needs.
- Nucleosome ctDNA (human, BDXXP4)
We recommend the use of our human DNA-free plasma products to produce complete workflow controls with this product. Blend the cfDNA as necessary with the DNA depleted plasma to receive plasma materials with the necessary DNA concentrations.
Datasheets and regulatory documentation
Everything your quality team needs for evaluation and procurement.
Instruction for Use
Frequently paired with this kit
Other assays and instruments lab teams add alongside the Nucleosome ctDNA.
Plasma 1x (Human-Tech) DNA Free 40 ml
Add this kit to your quote
Tell us the platforms and throughput you’re planning for and our specialists will put together a clear proposal with the right documentation, no public pricing, just a considered answer.
